Psychiatry - November 2008 - (Page 19)

[adverse events] Applying lessons learned from one institution may only be partially applicable to others. So we may have to categorize hospitals by tiers of complexity, establish standards or benchmarks, and work with each other to coordinate goals. consistent investment of time and attention by service or hospital leadership to effect change.9 The examination of psychiatric adverse events in a systematic, reportable format with transparency and clarity is in its fledgling stage. Progress is inevitable with more attention being paid to decrease untoward events and promoting quality. R, et al. What do we know about medication errors in Inpatient Psychiatry? Jt Comm J Qual Patient Saf. 2003; 29,(8):91–400. Pronovost PJ, Goeschel CA, Wachter RM. The wisdom and justice of not paying for “preventable complications.” JAMA. 2008;299,(18):2197–2199. Hiemke C. Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry. Eur J Clin Pharmacol. 2008;64,(2):159–166. Mauri MC, Volonteri LS, Colasanti A, et al. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response. Clin Pharmacokinetics. 2007;46,(5):359–388. 7. 8. 4. 9. Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval, Torsade de pointes and sudden death. Am J Psychiatry. 2001;158,(111):1774–1782. Meltzer HY, Davidson M, Glassman AH, et al. Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment. J Clin Psychiatry. 2002;63(Suppl 9:25–29. Bates DW, O’Neil AC, Petersen LA, etc. Evaluation of screening criteria for adverse events in medical patients. Medical Care. 1995;33,(5):452–462. 5. REFERENCES 1. Miller MR. Elixhauser A, Zhan C, et al. Patient safety indicators: using administrative data to identify potential patient safety concerns. Health Serv Res. 2001;36(6, part 2):110–132. Romano PS, Geppert JJ, Davies S, et al. A national profile of patient safety in US hospitals. Health Affairs. 2003.22,(2):154–166. Grasso BC, Rothschild JM, Genest 6. AUTHOR AFFILIATIONS: Dr. Jayaram is Associate Professor, Johns Hopkins University, Departments of Psychiatry and Health Policy and Management, Baltimore, Maryland. ADDRESS CORRESPONDENCE TO: Geetha Jayaram, MD, MBA, Department of Psychiatry, Johns Hopkins Hospital, 600 N. Wolfe St., Meyer 4-181, Baltimore, MD 21287; Phone: (410) 955-2237; Fax: (410) 614-8761; E-mail: gjayara1@jhmi.edu 2. 3. [NOVEMBER] Psychiatry 2008 19

Table of Contents Feed for the Digital Edition of Psychiatry - November 2008

Psychiatry - November 2008 Editor's Message Editorial Advisory Board Contents PsychRx Letters to the Editor Measuring Adverse Events in Psychiatry Nonsuicidal Self Injury in Adolescents Relative Tolerability of Alzheimer's Disease Treatments Biracial Identity Development and Recommendations in Therapy Depression and Cardiovascular Disease: Just an Urban Legend? Three Risk Management Basics Journal Watch Classified Advertising Information for Authors

Psychiatry - November 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.